Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes.
Gitto M, Leone PP, Gioia F, Chiarito M, Latini A, Tartaglia F, Kilic ID, Rossi ML, Regazzoli D, Gasparini G, Cozzi O, Sticchi A, Condorelli G, Reimers B, Stefanini G, Mangieri A, Colombo A.
Am J Cardiol. 2025 Mar 15;239:28-35. doi: 10.1016/j.amjcard.2024.12.008. Epub 2024 Dec 10.
PMID:39667516
Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?
Currier JW, Faxon DP.
J Am Coll Cardiol. 1995 Feb;25(2):516-20. doi: 10.1016/0735-1097(95)98445-j.
PMID:7829808
Coronary artery vasomotion after percutaneous transluminal coronary angioplasty.
Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions.
Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, Miyazaki R, Misawa T, Taomoto Y, Okata S, Nagase M, Horie T, Terui M, Kachi D, Odanaka Y, Matsuda K, Naito M, Koido A, Yonetsu T, Sasano T.